Precision Spine to introduce MD-Vue Lateral Access System featuring patented nested 3-blade design
Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, will introduce its MD-Vue Lateral Access System at the North American Spine Society (NASS) Annual Meeting October 26-29 in Boston, MA. The strong, lightweight MD-Vue System was designed in collaboration with prominent lateral spine surgeons and is the only lateral retractor that offers a unique and patented nested 3-blade design that prevents blade creep during insertion (U.S. Patent No. 8,986,344).
An adjunct 4th Blade Anterior Retraction option enables surgeons to increase the retraction field if necessary. MD-Vue features infinite resolution retraction, multiple fixation options and integrated LED lighting. The system will sell into a $1.2B worldwide market and is one of several innovative systems in the Precision Spine product development pipeline the company expects to become significant revenue drivers during the next phase of the its aggressive growth.
The MD-Vue Lateral Access System’s patented, nested 3-blade design is an innovative feature that enables surgeons to prevent blade creep in lateral procedures. It incorporates a large blade diameter for increased surface area contact, which minimizes the pressure on neural structures during retraction. In addition, the system’s radiolucent retractor increases visibility of critical anatomical structures during intraoperative C-Arm use. The system also features Infinite Cranial/Caudal Resolution, which is designed to prevent unwanted nerve pressure by permitting the surgeon to dial in precisely the desired amount of retraction, in contrast to other systems which permit only traditional incremental step retraction. In addition, the system features an industry-leading integrated, adjustable dual light source.
“With its many unique features, MD-Vue is a noteworthy advancement over existing lateral access systems and an outstanding platform from which we can continue to expand our presence in the lateral market,” said Jim Pastena, Precision Spine’s chief executive officer and chairman of the Board. “It’s a landmark addition to our portfolio and represents another example of how Precision Spine is working with spine surgeons to develop next generation products designed to help improve efficiency and achieve positive patient outcomes.”